| Carl Koch, APN, CRNA | |
|
355 Grand St, Jersey City, NJ 07302-4321 | |
| (201) 915-2000 | |
| Not Available |
| Full Name | Carl Koch |
|---|---|
| Gender | Male |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 10 Years |
| Location | 355 Grand St, Jersey City, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164843561 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | 26NR14308100 (New Jersey) | Secondary |
| 367500000X | Nurse Anesthetist, Certified Registered | 26NJ00486500 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Overlook Medical Center | Summit, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| North American Partners In Anesthesia Of New Jersey Llc | 5890867410 | 226 |
News Archive
Between 1994 and 2004, the number of singlehanded general practitioners in England fell from 2,959 to 1,918 (from 11% to 6% of all general practitioners). This contrasts sharply with the United States, where 46% of family practitioners and 34% of general internists were practising alone in 1998.
Creo Medical Group plc, a medical device company focused on the emerging field of surgical endoscopy, today announces that it has received 510(k) clearance ("FDA Clearance") from the US Food and Drug Administration for its Speedboat RS2 device and the CROMA platform.
Physicians may be able to safely lower the platelet dosage in transfusions for cancer and bone-marrow transplant patients without risking increased bleeding, according to new research involving UT Southwestern Medical Center and 28 other medical institutions.
Mimetogen Pharmaceuticals Inc. today announced positive top line data from the Phase II clinical trial of MIM-D3 for dry eye disease. The trial demonstrated statistically significant improvements in signs and symptoms with its low (1%) and high (5%) doses of MIM-D3, together with excellent safety and tolerability profiles.
› Verified 3 days ago
| Entity Name | American Anesthesiology Of New Jersey Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386654036 PECOS PAC ID: 0042112500 Enrollment ID: O20040123001039 |
News Archive
Between 1994 and 2004, the number of singlehanded general practitioners in England fell from 2,959 to 1,918 (from 11% to 6% of all general practitioners). This contrasts sharply with the United States, where 46% of family practitioners and 34% of general internists were practising alone in 1998.
Creo Medical Group plc, a medical device company focused on the emerging field of surgical endoscopy, today announces that it has received 510(k) clearance ("FDA Clearance") from the US Food and Drug Administration for its Speedboat RS2 device and the CROMA platform.
Physicians may be able to safely lower the platelet dosage in transfusions for cancer and bone-marrow transplant patients without risking increased bleeding, according to new research involving UT Southwestern Medical Center and 28 other medical institutions.
Mimetogen Pharmaceuticals Inc. today announced positive top line data from the Phase II clinical trial of MIM-D3 for dry eye disease. The trial demonstrated statistically significant improvements in signs and symptoms with its low (1%) and high (5%) doses of MIM-D3, together with excellent safety and tolerability profiles.
› Verified 3 days ago
| Entity Name | North American Partners In Anesthesia Of New Jersey Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548433048 PECOS PAC ID: 5890867410 Enrollment ID: O20080626000318 |
News Archive
Between 1994 and 2004, the number of singlehanded general practitioners in England fell from 2,959 to 1,918 (from 11% to 6% of all general practitioners). This contrasts sharply with the United States, where 46% of family practitioners and 34% of general internists were practising alone in 1998.
Creo Medical Group plc, a medical device company focused on the emerging field of surgical endoscopy, today announces that it has received 510(k) clearance ("FDA Clearance") from the US Food and Drug Administration for its Speedboat RS2 device and the CROMA platform.
Physicians may be able to safely lower the platelet dosage in transfusions for cancer and bone-marrow transplant patients without risking increased bleeding, according to new research involving UT Southwestern Medical Center and 28 other medical institutions.
Mimetogen Pharmaceuticals Inc. today announced positive top line data from the Phase II clinical trial of MIM-D3 for dry eye disease. The trial demonstrated statistically significant improvements in signs and symptoms with its low (1%) and high (5%) doses of MIM-D3, together with excellent safety and tolerability profiles.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Carl Koch, APN, CRNA 49 Middle Valley Rd, Long Valley, NJ 07853-3609 Ph: (908) 343-6190 | Carl Koch, APN, CRNA 355 Grand St, Jersey City, NJ 07302-4321 Ph: (201) 915-2000 |
News Archive
Between 1994 and 2004, the number of singlehanded general practitioners in England fell from 2,959 to 1,918 (from 11% to 6% of all general practitioners). This contrasts sharply with the United States, where 46% of family practitioners and 34% of general internists were practising alone in 1998.
Creo Medical Group plc, a medical device company focused on the emerging field of surgical endoscopy, today announces that it has received 510(k) clearance ("FDA Clearance") from the US Food and Drug Administration for its Speedboat RS2 device and the CROMA platform.
Physicians may be able to safely lower the platelet dosage in transfusions for cancer and bone-marrow transplant patients without risking increased bleeding, according to new research involving UT Southwestern Medical Center and 28 other medical institutions.
Mimetogen Pharmaceuticals Inc. today announced positive top line data from the Phase II clinical trial of MIM-D3 for dry eye disease. The trial demonstrated statistically significant improvements in signs and symptoms with its low (1%) and high (5%) doses of MIM-D3, together with excellent safety and tolerability profiles.
› Verified 3 days ago
Lynne Cartoccio, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 355 Grand St, Jersey City, NJ 07302 Phone: 201-915-2000 | |
Evelyn Coronado, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 355 Grand St, Jersey City, NJ 07302 Phone: 201-915-2000 Fax: 201-915-2701 | |
Fred Prendergass, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 355 Grand St, Jersey City, NJ 07302 Phone: 201-915-2405 | |
Donna-vivian V De Belen, C.R.N.A. Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 355 Grand St, Jersey City, NJ 07302 Phone: 201-915-2405 | |
Benedicta O Espinosa, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 355 Grand St, Jersey City, NJ 07302 Phone: 201-915-2000 Fax: 201-915-2701 | |
Allison Rose Roman, DNP, APN-CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 355 Grand St, Jersey City, NJ 07302 Phone: 201-915-2000 | |
Kyungmoon Roh, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 355 Grand St, Jersey City, NJ 07302 Phone: 201-915-2405 |